LIVER FIBROSIS IN ASIANS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE

被引：0
|
作者：
Kim, Byung Ik [1 ]
Sohn, Won [1 ]
Kwon, Heon-Ju [1 ]
Cho, Yong Kyun [2 ]
机构：
[1] Kangbuk Samsung Hosp, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Seoul, South Korea
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1705
引用
收藏
页码：1022A / 1022A
页数：1
相关论文
共 50 条
  • [21] Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease
    Perdomo, Carolina M.
    Nunez-Cordoba, Jorge M.
    Ezponda, Ana
    Mendoza, Francisco J.
    Ampuero, Javier
    Bastarrika, Gorka
    Fruhbeck, Gema
    Escalada, Javier
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [22] The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
    Goya, Takeshi
    Imoto, Koji
    Tashiro, Shigeki
    Aoyagi, Tomomi
    Takahashi, Motoi
    Kurokawa, Miho
    Suzuki, Hideo
    Tanaka, Masatake
    Kato, Masaki
    Kohjima, Motoyuki
    Ogawa, Yoshihiro
    [J]. GASTROENTEROLOGY INSIGHTS, 2022, 13 (01) : 20 - 26
  • [23] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Ting-Yao Wang
    Rui-Fang Wang
    Zhi-Ying Bu
    Giovanni Targher
    Christopher D. Byrne
    Dan-Qin Sun
    Ming-Hua Zheng
    [J]. Nature Reviews Nephrology, 2022, 18 : 259 - 268
  • [24] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    [J]. ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [25] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Wang, Ting-Yao
    Wang, Rui-Fang
    Bu, Zhi-Ying
    Targher, Giovanni
    Byrne, Christopher D.
    Sun, Dan-Qin
    Zheng, Ming-Hua
    [J]. NATURE REVIEWS NEPHROLOGY, 2022, 18 (04) : 259 - 268
  • [26] Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
    Lu, Chuan
    Chen, Yan
    Zhang, Yue
    Zhao, Xin
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2627 - 2637
  • [27] Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
    Lee, Chi-Ho
    Lui, David Tak-Wai
    Li, Raymond Hang-Wun
    Yuen, Michele Mae-Ann
    Fong, Carol Ho-Yi
    Leung, Ambrose Pak-Wah
    Chu, Justin Chiu-Man
    Mak, Loey Lung-Yi
    Lam, Tai-Hing
    Woo, Jean
    Woo, Yu-Cho
    Xu, Aimin
    Tse, Hung-Fat
    Tan, Kathryn Choon-Beng
    Cheung, Bernard Man-Yung
    Yuen, Man-Fung
    Lam, Karen Siu-Ling
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [28] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Shahinul Alam
    Shah Mohammad Fahim
    [J]. World Journal of Hepatology, 2021, 13 (10) : 1203 - 1207
  • [29] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Alam, Shahinul
    Fahim, Shah Mohammad
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (10) : 1203 - 1207
  • [30] ASSOCIATION OF THE METABOLIC STATUS WITH THE PRESENCE OF ADVANCED LIVER FIBROSIS IN MEXICAN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)
    Mendez-Guerrero, Osvely
    Cervera, Luis A. Chi
    Reyes, Raul Bernal
    Remes-Troche, Jose Maria
    Parra, Bryan Adrian Priego
    Vazquez, Sophia E. Martinez
    Amieva-Balmori, Mercedes
    Rodriguez, Leonardo A. Martinez
    Triana-Romero, Arturo
    Chavez, Maria E. Icaza
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S673 - S673
12345